DE69727155T2 - Dimesylatsalze von neuropeptiden und liganden - Google Patents

Dimesylatsalze von neuropeptiden und liganden Download PDF

Info

Publication number
DE69727155T2
DE69727155T2 DE69727155T DE69727155T DE69727155T2 DE 69727155 T2 DE69727155 T2 DE 69727155T2 DE 69727155 T DE69727155 T DE 69727155T DE 69727155 T DE69727155 T DE 69727155T DE 69727155 T2 DE69727155 T2 DE 69727155T2
Authority
DE
Germany
Prior art keywords
diseases
disorders
abnormal
compound according
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727155T
Other languages
German (de)
English (en)
Other versions
DE69727155D1 (de
Inventor
J. Douglas ALLEN
R. Lyle BROSTROM
S. Alireza KORD
A. Laurie WHIPPLE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69727155D1 publication Critical patent/DE69727155D1/de
Publication of DE69727155T2 publication Critical patent/DE69727155T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69727155T 1996-11-26 1997-11-19 Dimesylatsalze von neuropeptiden und liganden Expired - Fee Related DE69727155T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26
US31815P 1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en) 1996-11-26 1997-11-19 Dimesylate salts of neuropeptide y ligands

Publications (2)

Publication Number Publication Date
DE69727155D1 DE69727155D1 (de) 2004-02-12
DE69727155T2 true DE69727155T2 (de) 2004-07-08

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727155T Expired - Fee Related DE69727155T2 (de) 1996-11-26 1997-11-19 Dimesylatsalze von neuropeptiden und liganden

Country Status (23)

Country Link
US (1) US5914329A (https=)
EP (1) EP0944611B1 (https=)
JP (1) JP3120861B2 (https=)
AP (1) AP9701148A0 (https=)
AR (1) AR010304A1 (https=)
AT (1) ATE257472T1 (https=)
AU (1) AU4792497A (https=)
BR (1) BR9713538A (https=)
CA (1) CA2272927C (https=)
DE (1) DE69727155T2 (https=)
DK (1) DK0944611T3 (https=)
ES (1) ES2213207T3 (https=)
GT (1) GT199700123A (https=)
HN (1) HN1997000154A (https=)
HR (1) HRP970640A2 (https=)
ID (1) ID18964A (https=)
MA (1) MA26450A1 (https=)
PA (1) PA8441701A1 (https=)
PE (1) PE17099A1 (https=)
PT (1) PT944611E (https=)
TN (1) TNSN97191A1 (https=)
WO (1) WO1998023603A1 (https=)
ZA (1) ZA9710587B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
WO2003049673A2 (en) 2001-12-05 2003-06-19 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
ATE321865T1 (de) 2002-01-09 2006-04-15 Arexis Ab Mutationsnachweis
ES2333739T3 (es) * 2004-11-23 2010-02-26 Dong Wha Pharmaceutical Co., Ltd. Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico.
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
JP3120861B2 (ja) 2000-12-25
EP0944611A1 (en) 1999-09-29
JP2000505110A (ja) 2000-04-25
MA26450A1 (fr) 2004-12-20
GT199700123A (es) 1999-05-19
ID18964A (id) 1998-05-28
PT944611E (pt) 2004-04-30
PA8441701A1 (es) 2000-05-24
US5914329A (en) 1999-06-22
WO1998023603A1 (en) 1998-06-04
PE17099A1 (es) 1999-02-19
EP0944611B1 (en) 2004-01-07
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
DK0944611T3 (da) 2004-04-13
AU4792497A (en) 1998-06-22
BR9713538A (https=) 2000-03-21
TNSN97191A1 (fr) 2005-03-15
ZA9710587B (en) 1999-05-25
CA2272927A1 (en) 1998-06-04
ES2213207T3 (es) 2004-08-16
AP9701148A0 (en) 1998-01-31
HRP970640A2 (en) 1998-10-31
ATE257472T1 (de) 2004-01-15
AR010304A1 (es) 2000-06-07
HN1997000154A (es) 1999-02-09

Similar Documents

Publication Publication Date Title
DE69830409T2 (de) 4-aminopyrrole[3,2-d]pyrimidine als neuropeptid rezeptor antagonisten
DE69721541T2 (de) Einige amido-und amino-substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifischen liganden
DE69025305T2 (de) Polyamine verwendbar als Antagonisten von anregbaren Aminosäuren-Neurotransmittern
DD298412A5 (de) Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
DE69533194T2 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
DE2718405A1 (de) Neue n- eckige klammer auf 1-(3-benzoylpropyl)-4-piperidyl eckige klammer zu -sulfonsaeureamide und verfahren zu deren herstellung
DE69727155T2 (de) Dimesylatsalze von neuropeptiden und liganden
EP0665228B1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
DE69812010T2 (de) 4-Aminopyrrole (3,2-d) Pyrimidinen als Antagonisten des Neuropeptide Y Receptors
EP1335720A1 (de) Sulfonamiden zur behandlung von erkrankungen des zentralen nervensystems
EP0409048A2 (de) Aminoalkylsubstituierte 2-Aminothiazole und diese enthaltende therapeutische Mittel
DE69324492T2 (de) 1-azaadamantanderivate als 5-ht4 agonisten oder antagonisten und/oder 5-ht3 antagonisten
DE69922918T2 (de) Neuropeptid Y Antagonisten
DE2930608A1 (de) Alkylthiophenoxyalkylamine, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3423743A1 (de) Benzothiazepin-derivate und verfahren zu ihrer herstellung
EP1270576B1 (de) 3-Phenyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT390062B (de) Verfahren zur herstellung von neuen trifluormethyl substituierten tetracyclischen chinazolinonen und ihrer saeureadditionssalze
DD251982A5 (de) Verfahren zur herstellung von neuen in 11-stellung substituierten 5,11-dihydro-6h-pyride-(2,3-b)(1,4) benzodiazipin-6-onen
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE69718173T2 (de) Einige amido- und ammo- substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifische ligande
DE1620309C3 (de) Thieno-benzothiazin-Derivat und Verfahren zu seiner Herstellung
DE69619861T2 (de) 3-(2h)-pyridazinon derivate und diese verbindungen enthaltende pharmazeutische zusammensetzungen
WO2002018381A1 (de) ANTIKONVULSIV WIRKENDE 6,7-DIHYDRO-PYRROLO[3,4-b]PYRIDIN-5-ONE UND VERFAHREN ZU DEREN DARSTELLUNG
DE60220305T2 (de) Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten
EP0180889B1 (de) 3-Amino-2,3-dihydro-1-benzoxepin-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee